Maine cancer patients to get access to experimental drugs

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

PORTLAND, Maine (AP) — Maine residents will gain access to clinical research trials of new cancer-fighting drugs at Boston's Dana-Farber Cancer Institute under a partnership with MaineHealth.

MaineHealth is the parent company of Maine Medical Center, the largest hospital in the state. Maine Medical Center lead oncologist Scot Remick says the agreement gives Maine patients access to experimental treatments.

Remick says Maine has the highest rate of cancer in the country. The state has the oldest median age and it has about 9,000 new cancer patients every year. About 70 percent of the patients are treated in the MaineHealth network.

The Portland Press Herald ( ) reports patients won't have to leave Maine to participate in the trial in many cases. Some will be administered at Maine Medical Center Research Institute in Scarborough.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related topics

The Associated Press


    Catch up on the top news and features from, sent weekly.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast